[
[1]. T.W. Geisbert, P.B. Jahrling, Differentiation of filoviruses by electron microscopy, Virus Research 39 (1995) 129-150.10.1016/0168-1702(95)00080-1
]Search in Google Scholar
[
[2]. E. Picazo, F. Giordanetto, Small molecule inhibitors of Ebola virus infection, Drug Discovery Today 20 (2015) 277–286.10.1016/j.drudis.2014.12.01025532798
]Search in Google Scholar
[
[3]. World Health Organization (WHO). Ebola Situation Report March 30 (2016). https://www.who.int/csr/disease/ebola/en/
]Search in Google Scholar
[
[4]. J.J. Suschak, C.S. Schmaljohn Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates human, Vaccines and Immunotherapeutics 15 (2019) 2359-2377.
]Search in Google Scholar
[
[5]. S.A. Moghadam, Z. Abdollahi, S.R. Fakour, A. A. Moghaddam, F. Kiany, N. Damani, The Relationship Between Periodontal Disease and Public Health: A Population-Based Study, Global Journal of Health Science 8 (2015) 110-115. DOI: 10.5539/gjhs.v8n7p11010.5539/gjhs.v8n7p110496563826925886
]Search in Google Scholar
[
[6]. S. Baize, D. Pannetier, L. Oestereich, T. Rieger, L. Koivogui, N. Magassouba, B. Soropogui, M. S. Sow, S. Keïta,, H. De Clerck, A. Tiffany, G. Dominguez, M. Loua, A. Traoré, M. Kolié, E. R. Malano, E. Heleze,, A. Bocquin, S. Mély, H. Raoul, V. Caro, D. Cadar, M. Gabriel, M. Pahlmann, D. Tappe, J. Schmidt-Chanasit, B. Impouma, A. K. Diallo, P. Formenty, M. V. Herp, S. Günther, Emergence of Zaire Ebola virus disease in Guinea, New England Journal of Medivine 371 (2014) 1418-1425. DOI: 10.1056/NEJMoa140450510.1056/NEJMoa140450524738640
]Search in Google Scholar
[
[7]. R.K Singh, K. Dhama, Y.S. Malik, M. Andavar Ramakrishnan, K. Karthik, R. Khandia, R. Tiwari, A. Munjal, M. Saminathan, S. Sachan, P.A. Desingu, J.J. Kattoor, H.M.N. Iqbal, S.K. Joshi. Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year’s journey, Veterinary Quarterly 37 (2017) 98-135.
]Search in Google Scholar
[
[8]. F. Chiappelli, A. Bakhordarian, A.D. Thames, A.M. Du, A.L. Jan, M. Nahcivan, M.T. Nguyen, N. Sama, E. Manfrini, F. Piva, R.M. Rocha, C.A. Maida, Ebola: translational science considerations, Journal of Translational Medicine 13 (2015) 11-15.
]Search in Google Scholar
[
[9]. N.J. Beeching, M. Fenech, C.F. Houlihan, Critical Review: Ebola virus disease, British Medical Journal 349 (2014) g7348. DOI: 10.1136/bmj.g734810.1136/bmj.g7348470772025497512
]Search in Google Scholar
[
[10]. H. Ogawa, H. Miyamoto, E. Nakayama, R. Yoshida, I. Nakamura, H. Sawa, A. Ishii, Y. Thomas, E. Nakagawa, K. Matsuno, M. Kajihara, J. Maruyama, N. Nao, M. Muramatsu, M. Kuroda, E. Simulundu, K. Changula, B. Hang’ombe, B. Namangala, A. Nambota J. Katampi, M. Igarashi, K. Ito, H. Feldmann, C. Sugimoto, L. Moonga, A. Mweene, A. Takada, Seroepidemiological prevalence of multiple species of filoviruses in fruit bats (Eidolon helvum) migrating in Africa, Journal of Infectious Diseases 212 (2015) S101-S108.10.1093/infdis/jiv06325786916
]Search in Google Scholar
[
[11]. T. Ikegami, Molecular biology and genetic diversity of Rift Valley fever virus, Antiviral Research 95 (2012) 293-310.10.1016/j.antiviral.2012.06.001358693722710362
]Search in Google Scholar
[
[12]. O. Oluwagbemi, O. Awe, A comparative computational genomics of Ebola virus disease strains: Insilico insight for Ebola control, Informatics in Medicine Unlocked 12 (2018) 106– 119.
]Search in Google Scholar
[
[13]. M. Balmith, E.S. Soliman, Potential Ebola drug targets – filling the gap: a critical step forward towards the design and discovery of potential drugs, Journal Biologia 72 (2017) 1-13.
]Search in Google Scholar
[
[14]. M. Balmith, M. Faya, M.E. S. Soliman, Ebola virus: A gap in drug design and discovery - experimental and computational perspective, Chemical Biology and Drug Design 89 (2017) 297–308.
]Search in Google Scholar
[
[15]. B. Hartlieb, T. Muziol, W. Weissenhorn, S. Becker, Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association, Proceeding of National Academy of Science, USA 104 (2007) 624-629.10.1073/pnas.0606730104211139917202263
]Search in Google Scholar
[
[16]. Y. Guo, S.S. Dong, P. Yang, G.B. Li, B.C. Liu, C. Yang, Z.H. Rao, Crystal structure of Ebola virus nucleoprotein core domain at 1.8A resolution, Protein Cell 6 (2015) 351-362.10.1007/s13238-015-0163-3441767525910597
]Search in Google Scholar
[
[17]. R.N. Kirchdoerfer, C.L. Moyer, D.M. Abelson, E.O. Saphire, Ebola virus VP30 CTD bound to 8-nucleoprotein PLoS Pathog 12 (2016) e1005937.10.1371/journal.ppat.1005937506870727755595
]Search in Google Scholar
[
[18]. Spartan user’s guide, Wave function, Inc, Irvine, CA 92612 USA
]Search in Google Scholar
[
[19]. W.J. Hehre, L. Radom, P.V.R. Schleyer, J.A. Pope, Ab initio molecular Orbital Theory, Wiley, New York, 1988.
]Search in Google Scholar
[
[20]. A.D. Becke, Density-functional thermochemistry. III. The role of exact exchange, Journal Chemical Physics 98 (1993) 5648. DOI: 10.1063/1.46491310.1063/1.464913
]Search in Google Scholar
[
[21]. C. Lee, W. Yang, R.G. Parr, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Physical Review B 37 (1988) 785-789. DOI: 10.1103/physrevb.37.78510.1103/PhysRevB.37.785
]Search in Google Scholar
[
[22]. Spartan’14 Wavefunction, Inc. Irvine, CA, 2014
]Search in Google Scholar
[
[23]. M.N. Wass, L.A. Kelley, M.J.E. Sternberg, 3DLigandSite: predicting ligand-binding sites using similar structures, Nucleic Acids Research 38 (2010) W469–W473.10.1093/nar/gkq406289616420513649
]Search in Google Scholar
[
[24]. O. Trott, A.J. Olson, AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading, Journal of Computational Chemistry 31 (2010) 455–461.
]Search in Google Scholar
[
[25]. A.K Oyebamiji, E.K. Oladipo, T.M. Olotu, H.E. Awoyelu, E. Adamolekun, B. Semire, In-vitro Investigation on Selected compounds in Annona Muricata Seed: A Potential SARS-CoV nsp12 Polymerase Inhibitors down Regulating 2019-nCoV, International Journal of Traditional Natural Medicine 10 (2020) 13-23.
]Search in Google Scholar
[
[26]. A.K. Oyebamiji, G.F. Tolufashe, B. Semire, Inhibition study on anti-type 3 of 3α-hydroxysteroid dehydrogenase activity against 1,2,3-triazolo[4,5-D]pyrimidine derivatives: Molecular modelling approach, Scientific African 8 (2020) e00444.
]Search in Google Scholar
[
[27]. A.K. Oyebamiji, O.A Fadare, B. Semire, Hybrid-based drug design of 1,2,3-triazolepyrimidine-hybrid derivatives: Efficient inhibiting agents of mesenchymal–epithelial transition factor reducing gastric cancer cell growth, Journal of Chemical Research 44 (2020) 277-280. DOI: 10.1177/174751981989835410.1177/1747519819898354
]Search in Google Scholar
[
[28]. R.O. Oyewole, A.K. Oyebamiji, B. Semire, Theoretical Calculations of Molecular Descriptors for Anticancer Activities of 1,2,3-Triazolepyrimidine derivatives against Gastric cancer cell (MGC-803): DFT, QSAR and Docking Approaches, Heliyon 6 (2020) e03926. DOI: 10.1016/j.heliyon.2020.e0392610.1016/j.heliyon.2020.e03926724314132462084
]Search in Google Scholar
[
[29]. A.E. Adegbola, O.S. Fadahunsi, A.A. Ayodeji Z. Abijo, T.A. Balogun, T.S. Aderibigbe, B. Semire, P.I. Adegbola, Computational prediction of nimbanal as potential antagonist of respiratory syndrome coronavirus, Informatics in Medicine Unlocked 24 (2021) 100617. DOI: 10.1016/j.imu.2021.10061710.1016/j.imu.2021.100617816173634075339
]Search in Google Scholar
[
[30]. P.I. Adegbola, O.S. Fadahunsi, A.E. Adegbola, B. Semire, In silico studies of potency and safety assessment of selected trial drugs for the treatment of COVID-19, In Silico Pharmacology 9 (2001) 45. DOI: 10.1007/s40203-021-00105-x10.1007/s40203-021-00105-x829503034312587
]Search in Google Scholar
[
[31]. P.I. Adegbola, B. Semire, O.S. Fadahunsi A.E. Adegoke, Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19, Virus Disease 32 (2021) 85-97.10.1007/s13337-021-00682-7803601333869672
]Search in Google Scholar
[
[32]. A.K. Oyebamiji, S.A. Akintelu, O.P. Amao, M.O. Kaka, A.E. Morakinyo, F.A. Amao, B. Semire, Dataset on theoretical bio-evaluation of 1,2,4-thiadiazole-1,2,4-triazole Analogues against epidermal growth factor receptor kinase down regulating human lung cancer. Data in Brief. 37 (2021) 107234. DOI: 10.1016/j.dib.2021.10723410.1016/j.dib.2021.107234822056134195309
]Search in Google Scholar
[
[33]. M.A.F. Nasution, E.P. Toepak, A.H. Alkaff, U.S. Tambunan, Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola, BMC Bioinformatics 19 (2018) 419. DOI: 10.1186/s12859-018-2387-810.1186/s12859-018-2387-8624569230453886
]Search in Google Scholar
[
[34]. Y. Antonius, J. Ongko, J. Sukweenadhi, S.E. Dwi Putra, Identification of potential Ebola virus nucleoprotein (EBOV NP) inhibitor derivate from various traditional medicinal plants in Indonesia: in silico study, Media Pharmaceutica Indonesiana 3 (2021) 217-226.
]Search in Google Scholar
[
[35]. R.N. Kirchdoerfer, C.L. Moyer, D.M. Abelson, E.O. Saphire, The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis. PLoS Pathog 12 (2016) e1005937. DOI: 10.1371/journal.ppat.100593710.1371/journal.ppat.1005937506870727755595
]Search in Google Scholar
[
[36]. F. Darvas, G. Keseru, A. Papp, G. Dorman, L. Urge, P. Krajcsi, In Silico and Ex silico ADME approaches for drug discovery, Topics in Medicinal Chemistry 2 (2002) 1287–304.10.2174/156802602339284112470281
]Search in Google Scholar
[
[37]. H. Wen, H. Jung, X. Li, Drug delivery approaches in addressing clinical pharmacology-related issues: Opportunities and challenges, AAPS Journal 17 (2015) 1327–1340.
]Search in Google Scholar
[
[38]. C.A. Lipinski, Lead- and drug-like compounds: the rule-of-five revolution, Drug Discovery Today: Technologies 1 (2004) 337-341. DOI: 10.1016/j.ddtec.2004.11.00710.1016/j.ddtec.2004.11.00724981612
]Search in Google Scholar
[
[39]. A. Daina, V. Zoete, ABOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules, ChemMedChem 11 (2016) 1117– 1121.10.1002/cmdc.201600182508960427218427
]Search in Google Scholar
[
[40]. S.A. Attique, M. Hassan, M. Usman, R.M. Atif, S. Mahboob, K.A. Al-Ghanim, M. Bilal, M.Z. Nawaz, A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension, International Journal of Environmental Research and Public Health 16 (2019) 923. DOI: 10.3390/ijerph1606092310.3390/ijerph16060923646610230875817
]Search in Google Scholar
[
[41]. D.E.V. Pires, T.L. Blundell, D.B. Ascher, pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures, Journal of Medicinal Chemistry 58 (2015) 4066– 4072.
]Search in Google Scholar
[
[42]. M.J. Waring, J. Arrowsmith, A.R. Leach, P.D. Leeson, S. Mandrell, R.M. Owen, An analysis of the attrition of drug candidates from four major pharmaceutical companies, Natural Review of Drug Discovery 14 (2015) 475–486.10.1038/nrd460926091267
]Search in Google Scholar
[
[43]. D.A. Flockhart, Drug Interactions: cytochrome P450 Drug Interaction Table. Indiana University School of Medicine’/clinpharm/ddis/clinical-table/’’. 2007; Accessed August 12th 2018
]Search in Google Scholar
